NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...
Justice secretary urged to ‘show a bit of humanity’ with protesters severely ill after refusing food for weeks Who are the Palestine Action hunger strikers and what are the health risks? Families and ...
The jazz drummer Billy Hart said the decision was “evidently” connected to President Trump’s name being added to the arts center. By Adam Nagourney and Neil Vigdor A veteran jazz ensemble and a New ...
As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...
Companies must pay as much attention to the hard side of change management as they do to the soft aspects. By rigorously focusing on four critical elements, they can stack the odds in favor of success ...
TUSCALOOSA, Ala.— No. 18 Alabama (12-5, 2-2 SEC) had just eight scholarship players available in Tuesday night's road win at Mississippi State, and it's looking like it will likely be the same ...
An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...
Daniel Myers oversees client portfolios, investment policy at Kreger Financial and is the owner of Deep Fork LLC, a real estate investment firm. Eric's career includes extensive work in both public ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, ...
WAIKOLOA, Hawaii — In a panel discussion at Orthopedics Today Hawaii, Aaron J. Krych, MD, reviewed three papers on meniscus tears published in 2025 that have impacted his practice.
Jan. 16, 2026 A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results